Liquid-based cytology for primary cervical cancer screening: a multi-centre study

被引:0
作者
J Monsonego
A Autillo-Touati
C Bergeron
R Dachez
J Liaras
J Saurel
L Zerat
P Chatelain
C Mottot
机构
[1] Institut Alfred Fournier,Département de Pathologie
[2] Faculté de Médecine Nord,undefined
[3] Laboratoire Bio-cellulaire,undefined
[4] boulevard Pierre Dramard,undefined
[5] Laboratoires Pasteur Cerba,undefined
[6] LCL – Laboratoires Claude Lévy,undefined
[7] Laboratoire GRC,undefined
[8] Laboratoire I.H.C.P.,undefined
[9] Z.A. du Limancet,undefined
[10] Laboratoires Lavergne-Victor Hugo,undefined
[11] Phoenix International France,undefined
[12] Centre Georges François Leclerc,undefined
来源
British Journal of Cancer | 2001年 / 84卷
关键词
cervical smears; CIN; cervical cancer; ThinPrep cytology; cancer screening;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this six-centre, split-sample study was to compare ThinPrep fluid-based cytology to the conventional Papanicolaou smear. Six cytopathology laboratories and 35 gynaecologists participated. 5428 patients met the inclusion criteria (age > 18 years old, intact cervix, informed consent). Each cervical sample was used first to prepare a conventional Pap smear, then the sampling device was rinsed into a PreservCyt vial, and a ThinPrep slide was made. Screening of slide pairs was blinded (n = 5428). All non-negative concordant cases (n = 101), all non-concordant cases (n = 206), and a 5% random sample of concordant negative cases (n = 272) underwent review by one independent pathologist then by the panel of 6 investigators. Initial (blinded) screening results for ThinPrep and conventional smears were correlated. Initial diagnoses were correlated with consensus cytological diagnoses. Differences in disease detection were evaluated using McNemar’s test. On initial screening, 29% more ASCUS cases and 39% more low-grade squamous intraepithelial lesions (LSIL) and more severe lesions (LSIL+) were detected on the ThinPrep slides than on the conventional smears (P = 0.001), including 50% more LSIL and 18% more high-grade SIL (HSIL). The ASCUS:SIL ratio was lower for the ThinPrep method (115:132 = 0.87:1) than for the conventional smear method (89:94 = 0.95:1). The same trend was observed for the ASCUS/AGUS:LSIL ratio. Independent and consensus review confirmed 145 LSIL+ diagnoses; of these, 18% more had been detected initially on the ThinPrep slides than on the conventional smears (P = 0.041). The ThinPrep Pap Test is more accurate than the conventional Pap test and has the potential to optimize the effectiveness of primary cervical cancer screening. © 2001 Cancer Research Campaign http://www.bjcancer.com
引用
收藏
页码:360 / 366
页数:6
相关论文
共 84 条
[11]  
Kabawat SE(2000)Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity Am J of Manag Care 6 766-780
[12]  
Dupree WB(1998)Where’s the high-grade neoplasia? The importance of minimally abnormal Papanicolaou diagnoses Obstet Gynecol 91 73-76
[13]  
Suprun HZ(1989)The Papanicolaou test for cervical cancer detection: a triumph and a tragedy JAMA 261 737-743
[14]  
Beckwith DG(1997)Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening Obstet Gynecol 90 278-284
[15]  
Shane JJ(1997)The ThinPrep Pap Test: a review of clinical studies Acta Cytol 41 30-38
[16]  
Lucente V(1998)ThinPrep Papanicolaou testing to reduce false-negative cervical cytology Arch Pathol Lab Med 122 139-144
[17]  
Fender M(1999)Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results JAMA 281 1605-1610
[18]  
Schaffer P(1998)Evaluation of the ThinPrep Pap Test in clinical practice: a seven-month, 16,314-case experience in northern Vermont Acta Cytol 42 203-208
[19]  
Dellenbach P(1997)Evaluation of the ThinPrep Pap Test as an adjunct to the conventional Pap smear Med J Aust 167 466-469
[20]  
Gay J(1998)Dépistage des cancers du col de l’utérus en France [Screening for cancers of the uterine cervix in France] Gynécologie-Obstétrique Pratique 105 1-1008